222 related articles for article (PubMed ID: 24398669)
1. Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
Carcinogenesis; 2014 Jul; 35(7):1461-8. PubMed ID: 24398669
[TBL] [Abstract][Full Text] [Related]
2. Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
J Biol Chem; 2014 Jun; 289(26):18497-506. PubMed ID: 24838242
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure.
Lin YC; Owen N; Minko IG; Lange SS; Tomida J; Li L; Stone MP; Wood RD; McCullough AK; Lloyd RS
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13774-13779. PubMed ID: 27849610
[TBL] [Abstract][Full Text] [Related]
4. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
5. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
McCullough AK; Lloyd RS
DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
8. The aflatoxin B
Minko IG; Kellum AH; Stone MP; Lloyd RS
Environ Mol Mutagen; 2024 Apr; 65 Suppl 1(Suppl 1):9-13. PubMed ID: 37303259
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectra of aflatoxin B
Chawanthayatham S; Valentine CC; Fedeles BI; Fox EJ; Loeb LA; Levine SS; Slocum SL; Wogan GN; Croy RG; Essigmann JM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3101-E3109. PubMed ID: 28351974
[TBL] [Abstract][Full Text] [Related]
10. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
11. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
[TBL] [Abstract][Full Text] [Related]
12. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic potential of nitrogen mustard-induced formamidopyrimidine DNA adduct: Contribution of the non-canonical α-anomer.
Minko IG; Rizzo CJ; Lloyd RS
J Biol Chem; 2017 Nov; 292(46):18790-18799. PubMed ID: 28972137
[TBL] [Abstract][Full Text] [Related]
14. DNA damage checkpoint response to aflatoxin B1.
Engin AB; Engin A
Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
[TBL] [Abstract][Full Text] [Related]
15. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action.
Moore MM; Schoeny RS; Becker RA; White K; Pottenger LH
Crit Rev Toxicol; 2018 Apr; 48(4):312-337. PubMed ID: 29431554
[TBL] [Abstract][Full Text] [Related]
16. Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
Huang MN; Yu W; Teoh WW; Ardin M; Jusakul A; Ng AWT; Boot A; Abedi-Ardekani B; Villar S; Myint SS; Othman R; Poon SL; Heguy A; Olivier M; Hollstein M; Tan P; Teh BT; Sabapathy K; Zavadil J; Rozen SG
Genome Res; 2017 Sep; 27(9):1475-1486. PubMed ID: 28739859
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometry-Based Method to Measure Aflatoxin B
Bellamri M; Yao L; Tomar R; Vartanian V; Rizzo CJ; Stone MP; Groopman JD; Lloyd RS; Turesky RJ
Chem Res Toxicol; 2024 Apr; 37(4):633-642. PubMed ID: 38498000
[TBL] [Abstract][Full Text] [Related]
18. An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.
Kobertz WR; Wang D; Wogan GN; Essigmann JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9579-84. PubMed ID: 9275165
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
20. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]